FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224226274> ?p ?o ?g. }

• W4224226274 endingPage "734" @default.
• W4224226274 startingPage "717" @default.
• W4224226274 abstract "Abstract In the present study, we performed a comparative stage‐specific pathological and molecular marker evaluation of TMPRSS2‐ERG fusion and PTEN loss‐driven ( TMPRSS2‐ERG. Pten flox/flox ) versus non‐fusion‐driven prostate tumorigenesis ( Hi‐Myc ) in mice. Anterior, ventral, and dorsolateral prostates were collected from mice at different ages (or time points post‐ Cre induction). Results indicated that growth and progression of prostatic intraepithelial lesions to adenocarcinoma stages occurred in both mice models albeit at different rates. In the TMPRSS2‐ERG. Pten flox/flox mice, the initiation of tumorigenesis was slow, but subsequent progression through different stages became increasingly faster. Adenocarcinoma stage was reached early on; however, no high‐grade undifferentiated tumors were observed. Conversely, in the Hi‐Myc +/ − mice, tumorigenesis initiation was rapid; however, progression through different stages was relatively slower and it took a while to reach the more aggressive phenotype stage. Nevertheless, at the advanced stages in the Hi‐Myc +/ − mice, high‐grade undifferentiated tumors were observed compared to the later stage tumors observed in the fusion‐driven TMPRSS2‐ERG. Pten flox/flox mice. These results were corroborated by the stage specific‐pattern in the molecular expression of proliferation markers (PCNA and c‐Myc); androgen receptor (AR); fusion‐resultant overexpression of ERG; Prostein (SLC45‐A3); and angiogenesis marker (CD‐31). Importantly, there was a significant increase in immune cell infiltrations, which increased with the stage of tumorigenesis, in the TMPRSS2‐ERG fusion‐positive tumors relative to fusion negative tumors. Together, these findings are both novel and highly significant in establishing a working preclinical model for evaluating the efficacy of interventions during different stages of tumorigenesis in TMPRSS2‐ERG fusion‐driven PCa." @default.
• W4224226274 created "2022-04-26" @default.
• W4224226274 creator A5019213805 @default.
• W4224226274 creator A5027734680 @default.
• W4224226274 creator A5030886354 @default.
• W4224226274 creator A5042554532 @default.
• W4224226274 creator A5048444823 @default.
• W4224226274 creator A5052632084 @default.
• W4224226274 creator A5052676364 @default.
• W4224226274 creator A5062384041 @default.
• W4224226274 creator A5065631236 @default.
• W4224226274 creator A5072571061 @default.
• W4224226274 creator A5075084148 @default.
• W4224226274 creator A5082393215 @default.
• W4224226274 creator A5083317481 @default.
• W4224226274 creator A5084816440 @default.
• W4224226274 date "2022-04-22" @default.
• W4224226274 modified "2023-09-29" @default.
• W4224226274 title "Characterization of stage‐specific tumor progression in <i>TMPRSS2‐ERG</i> (fusion)‐driven and non‐fusion‐driven prostate cancer in GEM models" @default.
• W4224226274 cites W1965972536 @default.
• W4224226274 cites W1968093710 @default.
• W4224226274 cites W1970501568 @default.
• W4224226274 cites W1976677295 @default.
• W4224226274 cites W1980145933 @default.
• W4224226274 cites W1986799557 @default.
• W4224226274 cites W1992079095 @default.
• W4224226274 cites W1996447938 @default.
• W4224226274 cites W1998076166 @default.
• W4224226274 cites W2006619657 @default.
• W4224226274 cites W2007843050 @default.
• W4224226274 cites W2015437876 @default.
• W4224226274 cites W2016636564 @default.
• W4224226274 cites W2017225094 @default.
• W4224226274 cites W2021108594 @default.
• W4224226274 cites W2023011880 @default.
• W4224226274 cites W2024476936 @default.
• W4224226274 cites W2041002214 @default.
• W4224226274 cites W2049198834 @default.
• W4224226274 cites W2049205984 @default.
• W4224226274 cites W2050517163 @default.
• W4224226274 cites W2056646080 @default.
• W4224226274 cites W2062443670 @default.
• W4224226274 cites W2069467496 @default.
• W4224226274 cites W2070889512 @default.
• W4224226274 cites W2073417619 @default.
• W4224226274 cites W2082462837 @default.
• W4224226274 cites W2085033745 @default.
• W4224226274 cites W2085115464 @default.
• W4224226274 cites W2087207490 @default.
• W4224226274 cites W2089087147 @default.
• W4224226274 cites W2093789704 @default.
• W4224226274 cites W2094818686 @default.
• W4224226274 cites W2096800294 @default.
• W4224226274 cites W2099054500 @default.
• W4224226274 cites W2104400024 @default.
• W4224226274 cites W2104853034 @default.
• W4224226274 cites W2117936087 @default.
• W4224226274 cites W2121158863 @default.
• W4224226274 cites W2145941456 @default.
• W4224226274 cites W2146873467 @default.
• W4224226274 cites W2156383385 @default.
• W4224226274 cites W2160671186 @default.
• W4224226274 cites W2164942212 @default.
• W4224226274 cites W2170641343 @default.
• W4224226274 cites W2171943253 @default.
• W4224226274 cites W2176456200 @default.
• W4224226274 cites W2277018522 @default.
• W4224226274 cites W2512610215 @default.
• W4224226274 cites W2560317023 @default.
• W4224226274 cites W2620185811 @default.
• W4224226274 cites W2757396396 @default.
• W4224226274 cites W2903023870 @default.
• W4224226274 cites W2904083151 @default.
• W4224226274 cites W3012960536 @default.
• W4224226274 cites W4206841660 @default.
• W4224226274 cites W4211195653 @default.
• W4224226274 doi "https://doi.org/10.1002/mc.23413" @default.
• W4224226274 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35452553" @default.
• W4224226274 hasPublicationYear "2022" @default.
• W4224226274 type Work @default.
• W4224226274 citedByCount "1" @default.
• W4224226274 countsByYear W42242262742022 @default.
• W4224226274 crossrefType "journal-article" @default.
• W4224226274 hasAuthorship W4224226274A5019213805 @default.
• W4224226274 hasAuthorship W4224226274A5027734680 @default.
• W4224226274 hasAuthorship W4224226274A5030886354 @default.
• W4224226274 hasAuthorship W4224226274A5042554532 @default.
• W4224226274 hasAuthorship W4224226274A5048444823 @default.
• W4224226274 hasAuthorship W4224226274A5052632084 @default.
• W4224226274 hasAuthorship W4224226274A5052676364 @default.
• W4224226274 hasAuthorship W4224226274A5062384041 @default.
• W4224226274 hasAuthorship W4224226274A5065631236 @default.
• W4224226274 hasAuthorship W4224226274A5072571061 @default.
• W4224226274 hasAuthorship W4224226274A5075084148 @default.
• W4224226274 hasAuthorship W4224226274A5082393215 @default.
• W4224226274 hasAuthorship W4224226274A5083317481 @default.
• W4224226274 hasAuthorship W4224226274A5084816440 @default.
• W4224226274 hasBestOaLocation W42242262742 @default.

• next